ARROGENE, INC: 10-Q filed 2014-09-11
What ARROGENE, INC reported in its quarterly report filed 2014-09-11 (fiscal Q3 2014): 21 published measures, 55 facts as tagged in accession 0001376474-14-000313.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-09-11
- Fiscal period
- fiscal Q3 2014
- Accession
- 0001376474-14-000313 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ARROGENE, INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 333,073 | USD | |
| At 2013-10-31 | 29,236 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 1,530,294 | USD | |
| At 2013-10-31 | 491,651 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | -1,197,221 | USD | |
| At 2013-10-31 | -462,415 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 219,035 | USD | |
| At 2013-10-31 | 13,822 | USD | |
| At 2013-07-31 | 181,386 | USD | |
| At 2012-10-31 | 539,727 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-07-31 | -490,114 | USD | 92 |
| 2013-11-01 to 2014-07-31 | -1,268,145 | USD | 273 |
| 2013-05-01 to 2013-07-31 | -280,669 | USD | 92 |
| 2012-11-01 to 2013-07-31 | -784,458 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-11-01 to 2014-07-31 | -426,061 | USD | 273 |
| 2012-11-01 to 2013-07-31 | -585,986 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-11-01 to 2014-07-31 | 631,274 | USD | 273 |
| 2012-11-01 to 2013-07-31 | 227,645 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | -6,019,984 | USD | |
| At 2013-10-31 | -4,751,839 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 928 | USD | |
| At 2013-10-31 | 1,705 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-11-01 to 2014-07-31 | 344,883 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-07-31 | -395,324 | USD | 92 |
| 2013-11-01 to 2014-07-31 | -1,147,943 | USD | 273 |
| 2013-05-01 to 2013-07-31 | -280,391 | USD | 92 |
| 2012-11-01 to 2013-07-31 | -783,897 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 332,145 | USD | |
| At 2013-10-31 | 27,531 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-07-31 | 94,790 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 120,202 | USD | 273 |
| 2013-05-01 to 2013-07-31 | 278 | USD | 92 |
| 2012-11-01 to 2013-07-31 | 561 | USD | 273 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 1,530,294 | USD | |
| At 2013-10-31 | 491,651 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-07-31 | 395,324 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 1,147,943 | USD | 273 |
| 2013-05-01 to 2013-07-31 | 280,391 | USD | 92 |
| 2012-11-01 to 2013-07-31 | 783,897 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-07-31 | 312,827 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 876,494 | USD | 273 |
| 2013-05-01 to 2013-07-31 | 147,799 | USD | 92 |
| 2012-11-01 to 2013-07-31 | 466,813 | USD | 273 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-05-01 to 2014-07-31 | 82,497 | USD | 92 |
| 2013-11-01 to 2014-07-31 | 271,449 | USD | 273 |
| 2013-05-01 to 2013-07-31 | 132,592 | USD | 92 |
| 2012-11-01 to 2013-07-31 | 317,084 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 21,350,860 | shares | |
| At 2013-10-31 | 21,350,860 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | 4,820,625 | USD | |
| At 2013-10-31 | 4,287,289 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-07-31 | -1,197,221 | USD | |
| At 2013-10-31 | -462,415 | USD |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-11-01 to 2014-07-31 | 777 | USD | 273 |
| 2012-11-01 to 2013-07-31 | 1,174 | USD | 273 |
Inspect the source
- Entity
- ARROGENE, INC / CIK 0001403792
- Captured
- SEC response SHA-256
e9c8c3a7f77b1fda5c670b336964f271e208cc4ac5926c5ea0b29419f435a588
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001403792.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))